Maimonides is offering COVID-19 vaccine appointments to those who are eligible per city, state, and federal guidelines. Please do not call or email to request an appointment. We are notifying eligible individuals as supplies become available.

Cancer Type: Bladder

A Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) In Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR).

Learn more about active clinical trials at Maimonides